Solopharm announces the launch of its new drug, Angidak® Intensive, developed for the fast and comprehensive relief of sore throat pain. The new product is already available on Apteka.ru and will soon appear in all major federal pharmacy chains.
Angidak® Intensive is an innovative product with an original, patented formula created by Solopharm experts based on the synergy of three active components:
- Benzydamine – Reduces inflammation and pain.
- Octenidine – Provides antimicrobial action.
- Phenoxyethanol – Enhances the antimicrobial effect.
The combination of these substances delivers a powerful triple action – against viruses, bacteria, and fungi – making the drug a reliable solution for the most common causes of sore throat.
- Active against viruses, bacteria, and fungi.
- Helps reduce sore throat pain from the first minute.
- Provides an anti-inflammatory effect.
The launch of Angidak® Intensive is another step for Solopharm in expanding its portfolio of modern and accessible solutions for health maintenance.
«Angidak® Intensive is our response to patient demand for fast and reliable relief from sore throat pain. We continue to strengthen our portfolio with innovative products that help maintain quality of life during the cold and flu season and all year round», commented the Solopharm press center.